Search results
Novartis Gets FDA Breakthrough Therapy Designation for Scemblix
Market Watch· 10 hours agoNovartis said the U.S. drug regulator decided to expedite the development of Scemblix, to treat adults newly diagnosed with leukemia. The Swiss pharmaceutical< ...
TFF Pharmaceuticals (NASDAQ:TFFP) vs. Alnylam Pharmaceuticals (NASDAQ:ALNY) Financial Contrast
ETF DAILY NEWS· 17 hours agoAlnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) and TFF Pharmaceuticals (NASDAQ:TFFP – Get Free Report) are both medical companies, but which is ...
Drugmakers in Medicare negotiations spent more on shareholder payments and marketing than R&D last...
The Hill via Yahoo Finance· 2 days agoA new report from the center-left watchdog group Accountable US found that most major drugmakers...
2 Magnificent Dividend Stocks to Hold for the Next Decade
Motley Fool via Yahoo Finance· 5 days agoNovartis (NYSE: NVS) and Visa (NYSE: V). 1. Novartis What makes a drugmaker like Novartis a great...
The Interplay: Key Decisions at the Intersection of Antitrust & Life Sciences - April 2024 | JD...
JD Supra· 4 days agoThis week, the FTC continued its intense regulatory focus on pharmaceutical patents listed in the FDA’s Orange Book. As reported in earlier editions of The Interplay, the ...
Brain waste: College-educated adult immigrants struggle to work in their fields in the U.S.
WLRN Miami· 1 day agoClaudia Londoño recalls her first job in the United States in 2021. At that moment, memories of the years she spent earning her bachelor’s and master’s degrees flooded her mind. Londoño is a ...
Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
Zacks via Yahoo Finance· 2 days agoZacks Rank Ionis currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks...
Drugmakers in Medicare Price Talks Spent Less on R&D Than on Shareholders, Marketing, Overhead:...
The Fiscal Times via Yahoo Finance· 1 day agoThe report says that the eight companies — Johnson & Johnson, Amgen, AstraZeneca, Bristol Myers...
Questor: this medical stock is expensive – but worth paying for
The Telegraph via Yahoo Finance· 5 days agoIt’s a stock market rule of thumb that big acquisitions tend to destroy shareholder value....
Big Pharma layoffs continue, as Bristol-Myers Squibb cuts 2,200 jobs, $1.5B in costs
BenefitsPRO· 10 hours agoAt a time when drugmakers Eli Lilly & Co. and Novo Nordisk are scrambling to meet demand for their...